PartnerTx retweeted
🧠 Sponsor Spotlight: @PartnerTx On #NationalHealthcareDecisionsDay, we recognize the importance of informed, timely trauma care. Thanks to @PartnerTx for advancing immunotherapy that supports decision-making in critical trauma settings.
🌐 partnertx.com
#THOR #RDCR
PartnerTx retweeted
Check out : Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment. cell.com/cell-reports-medici… first clinical application of the macrophage niche concept with @MartinGuilliams
PartnerTx retweeted
Announcing the PAP Education Day Travel Reimbursement Program! We're offering patients travel reimbursement up to a set amount for those who could not otherwise attend the Michigan Education Day on a first-come, first-served basis. Apply here: forms.gle/XG9eQWon4CfzC3VY6
PartnerTx retweeted
Dr. Isabel Lauren Jackson from @UMmedschool spoke to @CNNBusiness about Leukine, a drug developed to help in the recovery of white blood cells following chemotherapy or radiation therapy. cnn.com/2022/03/29/business/…
PartnerTx retweeted
Thanks so much to @kweintraub for her important article in @USATODAY about the power of #DrugRepurposing! I'm honored to be #ChasingMyCure & #ChasingCures alongside @mattmight and other #Raredisease warriors! usatoday.com/in-depth/news/h…
PartnerTx retweeted
New Research: The Role of GM-CSF Autoantibodies in Infection and Autoimmune Pulmonary Alveolar Proteinosis: A Concise Review: Autoantibodies to multiple cytokines have been identified and some, including antibodies against… frontiersin.org/articles/10.… #immunology
PartnerTx retweeted
Announcing a brand new PAP CME program! Share with your PAP clinicians! Link : mycme.com/courses/know-how-t…
PartnerTx retweeted
UK reopening delay underlines the need to learn to live with Covid-19 - londonlovesbusiness.com/uk-r…
PartnerTx retweeted

Ian Kremer@LEAD_Coalition21 Jun 2021
United States
United StatesConnected via United States App StoreAccount-level information, not a live location or per-post device.
‘Cautiously Optimistic:’ #Cancer Drug May Improve Memory in #Alzheimers beingpatient.com/cancer-drug…
#dementia @VirusesImmunity @SuzanneLepage1 @GavinPrestonMD @LizSzabo @SusanneLeist @VincentRK @themerry_monk @DNABARCODE @cooljim198 @Crazy_Mama_G @PollyPapaya @lawrence_wray @jim1036
PartnerTx retweeted
Just published @fsgimt
Part of our assessment of #immunotherapy triplet combination candidates.
We review #rhuGMCSF preclinical, clinical & translational data & the underlying mechanisms supporting enhanced efficacy & reduced immune toxicity
futuremedicine.com/doi/10.22…
PartnerTx retweeted
#TannerGAP fields international inquiries & works w/physicians, hospitals & ministries of health to provide medicine that is not currently available in their country. Learn more about our services and the Leukine Access Program (LeAP): tannerpharma.com/our-impact/…
PartnerTx retweeted
Excited to share our lab’s first @biorxivpreprint: biorxiv.org/content/10.1101/…
We clarified important GM-CSF and alveolar macrophage biology in this outstanding work by Samantha Sherman and Julia Gschwend in their first year of PhD, in collaboration with LocksleyLab and @BecherLab
PartnerTx retweeted
Biogen spent $1 billion on neuro drug candidates, the Longwood Fund launched a new incubator and another biotech planned an IPO this week. Did you catch all of the news? Read it here, in The Petri Dish. bizjournals.com/boston/news/…
PartnerTx retweeted
Conference in the time of Corona with #ASGCT20!
Thank you to these wonderful faces (clockwise fr top L): co-chair Debasish Roychowdhury @PartnerTx, Delfi Krishna @GSK, Rogerio Vivaldi @Sigilon_Inc, co-chair @katyspinkdhcg, Katherine Tsokas @JanssenGlobal, and John Doyle @pfizer.
PartnerTx retweeted
The @PAP_Foundation officially supports inhaled GM-CSF therapy as a treatment for aPAP patients and encourages FDA approval! Read more and see the full press release here: bit.ly/2Jmz1Ml


















